X

Xeris Biopharma Holdings
D

XERS

3.08000
USD
0.03
(0.98%)
Market Closed
Volume
15,887
EPS
-0
Div Yield
-
P/E
-7
Market Cap
459,170,900
OverviewSignalsIdeasNews
Related Instruments
    A
    ALDX
    -0.06000
    (-1.41%)
    4.20000 USD
    A
    AQST
    -0.13000
    (-2.84%)
    4.44500 USD
    B
    BHC
    -0.27000
    (-3.08%)
    8.48500 USD
    E
    EPIX
    -0.04000
    (-2.27%)
    1.72500 USD
    E
    ESPR
    0.03000
    (1.43%)
    2.13000 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    INSM
    -4.950
    (-6.95%)
    66.310 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.16 USD
    R
    RDHL
    0.24000
    (3.40%)
    7.29000 USD
    S
    SAGE
    -0.26000
    (-4.84%)
    5.11000 USD
    More
News

Title: Xeris Biopharma Holdings

Sector: Healthcare
Industry: Biotechnology
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.